|
|
|
|
Are you registered for the upcoming 2020 AHA Scientific Sessions?
|
|
We are excited to share updates for our investigational agent sotatercept with 3 information sessions, plus a virtual booth page in the AHA Virtual Exhibit Hall, for you to explore.
|
|
Join us for these sessions and dive deeper into a review of key clinical trial data:
|
|
Abstract Oral Session
|
|
|
|
Session Title: Dickinson W. Richards Memorial Lecture
|
|
Presenter: Vallerie McLaughlin, MD
|
| Cardiopulmonary Best Abstract Award |
|
Abstract Title: Sotatercept Improves Right Ventricular - Pulmonary Arterial Coupling and Right Ventricular Function in the PULSAR Study: A Phase 2, Double-blind, Placebo-controlled, Randomized Study to Compare the Efficacy and Safety of sotatercept versus Placebo when Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
|
|
|
|
|
|
|
Cardiovascular Seminar
|
|
|
|
Session Title: Pulmonary Hypertension Clinical Trials with Novel Approaches
|
|
Presenter: Aaron B. Waxman, MD, PhD
|
|
Presentation Title: SPECTRA and Beyond: Signs of Disease Modification?
|
|
|
|
|
|
|
Moderated Digital Poster
|
|
|
|
Session Title: Targeting Right Ventricular Dysfunction in PAH
|
|
Presenter: Sachindra Joshi, PhD
|
|
Abstract Title: Sotatercept Analog RAP-011 Inhibits Right Ventricular Remodeling and Restores Function in a Mouse Model of Pressure Overload
|
|
|
|
|
|
|
Visit our virtual booth page in the AHA Virtual Exhibit Hall to learn more about the work Acceleron is doing in PAH.
|
|
|
|
|
|